摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(RS)-5-cyclohex-1-enyl-3-[(trans-4-methyl-cyclohexanecarbonyl)-(2-methyl-1,3-dioxo-octahydro-isoindol-5-yl)-amino]-thiophene-2-carboxylic acid | 915215-88-2

中文名称
——
中文别名
——
英文名称
(RS)-5-cyclohex-1-enyl-3-[(trans-4-methyl-cyclohexanecarbonyl)-(2-methyl-1,3-dioxo-octahydro-isoindol-5-yl)-amino]-thiophene-2-carboxylic acid
英文别名
——
(RS)-5-cyclohex-1-enyl-3-[(trans-4-methyl-cyclohexanecarbonyl)-(2-methyl-1,3-dioxo-octahydro-isoindol-5-yl)-amino]-thiophene-2-carboxylic acid化学式
CAS
915215-88-2
化学式
C28H36N2O5S
mdl
——
分子量
512.67
InChiKey
MTWWHBVJMNQURP-PGNWLTJSSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.35
  • 重原子数:
    36.0
  • 可旋转键数:
    5.0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.64
  • 拓扑面积:
    94.99
  • 氢给体数:
    1.0
  • 氢受体数:
    5.0

反应信息

点击查看最新优质反应信息

文献信息

  • Compounds and methods for the treatment or prevention of Flavivirus infections
    申请人:Denis Real
    公开号:US20060276533A1
    公开(公告)日:2006-12-07
    Compounds represented by formula I: or pharmaceutically acceptable salts and solvates thereof, wherein R 1 , X, Y, Y 1 , and Z are as defined herein, are useful for treating flaviviridae viral infections.
    公式I所代表的化合物或其药用可接受的盐和溶剂化物,其中R1、X、Y、Y1和Z的定义如本文所述,可用于治疗黄病毒科病毒感染。
  • COMPOUNDS AND METHODS FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
    申请人:DENIS Real
    公开号:US20100093775A1
    公开(公告)日:2010-04-15
    Compounds represented by formula I: or pharmaceutically acceptable salts and solvates thereof, wherein R 1 , X, Y, Y 1 , and Z are as defined herein, are useful for treating flaviviridae viral infections.
    式I所代表的化合物或其药学上可接受的盐和溶剂化物,其中R1、X、Y、Y1和Z的定义如本文所述,可用于治疗黄病毒科病毒感染。
  • Compounds and Methods for the Treatment or Prevention of Flavivirus Infections
    申请人:Denis Real
    公开号:US20120164103A1
    公开(公告)日:2012-06-28
    Compounds represented by formula I: or pharmaceutically acceptable salts and solvates thereof, wherein R 1 , X, Y, Y 1 , and Z are as defined herein, are useful for treating flaviviridae viral infections.
    以式子I所代表的化合物或其药学上可接受的盐和溶剂化物,其中R1,X,Y,Y1和Z的定义如本文所述,可用于治疗黄病毒科病毒感染。
  • Compounds and methods for the treatment or prevention of flavivirus infections
    申请人:Virochem Pharma Inc.
    公开号:EP2543664A1
    公开(公告)日:2013-01-09
    Compounds represented by formula I: or pharmaceutically acceptable salts and solvates thereof, wherein R1, X, Y, Y1, and Z are as defined herein, are useful for treating flaviviridae viral infections.
    式 I 所代表的化合物: 或其药学上可接受的盐和溶液,其中 R1、X、Y、Y1 和 Z 如本文所定义,可用于治疗黄病毒科病毒感染。
  • US7569600B2
    申请人:——
    公开号:US7569600B2
    公开(公告)日:2009-08-04
查看更多

同类化合物

酮替芬EP杂质A 酮替芬 苯噻啶苹果酸盐 苯噻啶盐酸盐 苯噻啶 益托洛替芬 富马酸酮替芬 去甲酮替芬富马酸氢盐 乙基2-[(乙基氨基甲硫杂酰)氨基]-5,6,7,8-四氢-4H-环庚三烯并[b]噻吩-3-羧酸酯 [2,3-d]噻吩并环庚三烯酮 9-氧代酮替芬 9,10-二溴-9,10-二氢-4H-苯并[4,5]环庚并[1,2-b]噻吩-4-酮 9,10-二氧代酮替芬 9, 10-二氢-4H-苯并[4, 5]环庚三烯[1, 2-b]噻吩-4-酮 6H-环庚三烯并[c]噻吩-6-酮,1,3,5,7-四甲基- 5,6,7,8-四氢-4h-环庚基[b]噻吩-2-羧酸 5,6,7,8-四氢-4H-环庚[b]噻吩-2-羧酸酰肼 4H-环庚三烯并[b]噻吩-3-羧酸,5,6,7,8-四氢-2-[3-(羟甲基)-5-甲基-4H-1,2,4-三唑-4-基]-,甲基酯 4-羟基酮替芬 4-(哌啶-4-亚基)-4H-苯并[4,5]环庚三烯并[1,2-B]噻吩-10(9H)-酮 4-(3'-甲基氨基丙基亚基)-9,10-二氢-4H-苯并(4,5)环庚并(1,2-b)噻吩 4,9-二氢-4-(1-甲基-4-哌啶基亚基)-10H-苯并[4,5]环庚三烯并[1,2-b]噻吩-10-酮 N-氧化物; 酮替芬 N-氧化物 2-溴-9,10-二氢-4H-苯并(4,5)环庚并(1,2-b)噻吩-4-酮 2-氯-N-(3-氰基-5,6,7,8-四氢-4H-环戊并[b]噻吩-2-基)-乙酰胺 2-氨基环庚烷并[B]噻吩-3-羧酸乙酯 2-氨基-N-甲基-5,6,7,8-四氢-4H-环庚并[b]噻吩-3-甲酰胺 2-氨基-N-乙基-5,6,7,8-四氢-4H-环庚并[b]噻吩-3-甲酰胺 2-氨基-5,6,7,8-四氢-4H-环庚基[b]噻吩-3-羧酰胺 2-氨基-5,6,7,8-四氢-4H-环庚基[b]噻吩-3-甲腈 2-氨基-5,6,7,8-四氢-4H-环庚[B]噻吩-3-甲酸甲酯 2-乙酰氨基-5,6,7,8-四氢-4H-环庚并[b]噻吩-3-羧酸 2-[(3-氯-1-氧代丙基)氨基]-5,6,7,8-四氢-4H-环庚并[b]噻吩-3-羧酸乙酯 2-(2-氯乙酰基氨基)-5,6,7,8-四氢-4H-环庚[b]噻吩-3-羧酸乙酯 10-甲氧基-4H-苯并[4,5]环庚三烯并[1,2-b]噻吩-4-酮 10-甲氧基-4-(1-甲基-4-哌啶基)-4H-苯并[4,5]环庚三烯并[1,2-B]噻吩-4-醇 1,3-二氢-1-[1-[(5,6,7,8-四氢-4H-环庚[b]噻吩-2-基)羰基]-4-哌啶基]-2H-苯并咪唑-2-酮 (3E)-3-(9,10-二氢-4H-苯并[4,5]环庚三烯并[1,2-b]噻吩-4-亚基)-N,N-二甲基丙烷-1-胺 (+/-)-10-<3-Dimethylamino-propyl>-4,5-dihydro-10H-benzo<5,6>cyclohepta<1,2-b>thiophen-10-ol methyl 2-[3-(acetylamino)-6-methyl-7-oxo-4,5,6,7-tetrahydrobenzo[b]thiophen-6-yl]acetate 10-<3-Dimethylamino-propyliden>-4,5-dihydro-10H-benzo<5,6>-cyclohepta<1,2-b>thiophen ethyl 3-[4-(1-methylpiperidin-4-ylidene)-10-oxo-9,10-dihydro-4H-1-thiabenzo[f]azulen-2-yl]acrylate 2-t-butoxycarbonylamino-4-(1-methylpiperidin-4-ylidene)-9,10-dihydro-4H-1-thiabenzo[f]azulene ethyl 4-[1-(2-ethoxyethyl)piperidin-4-ylidene]-9,10-dihydro-4H-1-thiabenzo[f]azulene-2-carboxylate hydrochloride Ethyl 4-(1-propylpiperidin-4-ylidene)-9,10-dihydro-4H-1-thiabenzo[f]azulene-2-carboxylate hydrochloride 4-(6-chloro-2-methyl-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene)-1-methyl-piperidine methyl 2-[2-(acetylamino)-6-methyl-7-oxo-4,5,6,7-tetrahydrobenzo[b]thiophen-6-yl]acetate 2-ureidomethyl-4-(1-methylpiperidin-4-ylidene)-9,10-dihydro-4H-1-thiabenzo[f]azulene 2-[2-(9,10-dihydro-benzo[4,5]cyclohepta[1,2-b]thiophen-4-ylidene)-ethyl]-piperidine-1-carboxylic acid ethyl ester 4-[1-(2-ethoxyethyl)piperidin-4-ylidene]-9,10-dihydro-4H-1-thiabenzo[f]azulene-2-carboxylic acid